TG Therapeutics Inc (TGTX)
16.48
-0.94
(-5.40%)
USD |
NASDAQ |
May 17, 16:00
16.48
0.00 (0.00%)
After-Hours: 20:00
TG Therapeutics Cash from Investing (Quarterly): -9.255M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -9.255M |
December 31, 2023 | -44.76M |
September 30, 2023 | -30.23M |
June 30, 2023 | 30.50M |
March 31, 2023 | -6.168M |
December 31, 2022 | 16.27M |
September 30, 2022 | -2.99M |
June 30, 2022 | 10.38M |
March 31, 2022 | -43.67M |
December 31, 2021 | 3.288M |
September 30, 2021 | -0.631M |
June 30, 2021 | -2.475M |
March 31, 2021 | -0.514M |
December 31, 2020 | -52.08M |
September 30, 2020 | 14.91M |
June 30, 2020 | 11.20M |
March 31, 2020 | 1.45M |
December 31, 2019 | 0.004M |
September 30, 2019 | -0.044M |
June 30, 2019 | 0.457M |
March 31, 2019 | -1.135M |
December 31, 2018 | 0.238M |
September 30, 2018 | -6.435M |
June 30, 2018 | 5.585M |
March 31, 2018 | 1.792M |
Date | Value |
---|---|
December 31, 2017 | -28.01M |
September 30, 2017 | 8.80M |
June 30, 2017 | 4.998M |
March 31, 2017 | 6.00M |
December 31, 2016 | 11.48M |
September 30, 2016 | 15.58M |
June 30, 2016 | 1.414M |
March 31, 2016 | -1.924M |
December 31, 2015 | 2.478M |
September 30, 2015 | 0.0766M |
June 30, 2015 | -31.08M |
March 31, 2015 | 3.843M |
December 31, 2014 | -9.133M |
September 30, 2014 | -0.0013M |
June 30, 2014 | -9.218M |
March 31, 2014 | -0.0032M |
December 31, 2013 | -4.922M |
September 30, 2013 | -0.0016M |
June 30, 2013 | -0.0017M |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | -0.0014M |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.0104M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-52.08M
Minimum
Dec 2020
30.50M
Maximum
Jun 2023
-5.217M
Average
-0.279M
Median
Cash from Investing (Quarterly) Benchmarks
Amicus Therapeutics Inc | 7.537M |
Geron Corp | 34.21M |
Editas Medicine Inc | -4.745M |
G1 Therapeutics Inc | 5.289M |
Mersana Therapeutics Inc | -72.55M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -8.207M |
Cash from Financing (Quarterly) | 0.01M |
Free Cash Flow | 20.28M |
Free Cash Flow Per Share (Quarterly) | -0.0561 |
Free Cash Flow to Equity (Quarterly) | -9.415M |
Free Cash Flow to Firm (Quarterly) | -5.913M |
Free Cash Flow Yield | 0.82% |